CPRX Dec 2024 12.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:57AM EDT. Market open.
| Previous close | 5.08 |
| Open | 5.08 |
| Bid | 2.75 |
| Ask | 4.10 |
| Strike | 12.50 |
| Expiry date | 2024-12-20 |
| Day's range | 5.08 - 5.08 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
ZacksWhy Is Catalyst (CPRX) Up 0.7% Since Last Earnings Report?
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Simply Wall St.Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Been Rising: Are Strong Financials Guiding The Market?
Most readers would already know that Catalyst Pharmaceuticals' (NASDAQ:CPRX) stock increased by 4.1% over the past...
GlobeNewswireCatalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®
CORAL GABLES, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that the U.S. Food and Drug Administration (“FDA”) has approved its supplemental New Drug Application (“sNDA”) increasing the indicated maximum daily dose of FIRDAPSE® (amifampr
© 2024 Yahoo. All rights reserved.